Stocks to Buy

Whether you are a novice who just opened your first 401k or you are a seasoned investor, you have to spend countless hours researching stocks to buy. Who has that kind of time? We do. Powered by a diverse group of perspectives formed from dozens of analysts, advisors and strategists, our stories digest the day’s biggest headlines to uncover which stocks you should buy.

The Bull Case for Shopify Stock Is More Relevant Than Ever

Shopify stock may look overvalued, but that’s only temporary. In the long run, shares of SHOP stock will ride the e-commerce mega-wave.

My Stock Pick From the Best Sector This Year

The sky is not falling and there is even a group of stocks that is not only surviving but thriving in this environment.

3 Up-and-Coming Drug Stocks to Buy Now

These drug stocks all have tremendous potential as these small companies work to treat widespread diseases in the U.S. and beyond.

Despite Naysayers, Nio Stock Still a Long-Term Bet on China’s Growth

NIO stock has risks. But too often the coverage focuses on those risks — and not the enormous opportunity in front of the company.

Earnings Erase Key Doubts About Amazon Stock

Amazon stock soared after earnings — but not just because of the headline beat. Key aspects of the report should calm investor worries.

Trade Delta Air Lines Stock and Stay Immune From the Coronavirus

Coronavirus headlines have wreaked havoc on the travel industry. But DAL stock has corrected and now it's time to be bullish.

Nokia Stock Continues to Slide As Huawei Scores a 5G Win, Q4 Earnings Loom

NOK stock has been on a downward trajectory since mid-January, a situation made worse when Huwaei won a 5G victory in the U.K.

ADBE Stock Is All but Certain to Hit $400 This Year

Shortly after Adobe reported its Q4 2019 results in December, InvestorPlace’s Luke Lango, highlighted the many reasons the company’s stock is a long-term winner. That’s because Adobe’s captured a niche part of the cloud, ensuring that its sales continue to grow for years to come.

What to Expect From General Electric as Its Turnaround Accelerates

General Electric is clearly in the midst of a big turnaround, and GE stock is looking like a great stock to buy now.

Driver Assistance Systems Could Shift Qualcomm Stock Into High Gear

Although 5G represents the bulk of the investment argument for Qualcomm stock, investors should also look at the underlying company’s contributions toward advanced driver-assistance systems (ADAS).

Microsoft Stock Is Worth the Premium as the Cloud Megatrend Continues

Microsoft is certainly back in a big way. In the latest quarter, the company showed that the growth is very durable.

10 Tech Stocks to Buy Now for 2025

A recent report from RBC Capital Markets reveals tech's best stocks to buy now that are most likely to outperform over the next seven years.

Twilio Earnings Preview: TWLO Stock Could Be This Year’s Market Darling

Twilio's long-term growth story looks intact regardless of whether its billing issues persisted in Q4. But if the firm lives up to expectations, it could add to TWLO stock's already impressive rally.

Current Uncertainty Allows Investors to Get Into JD Stock at a Discount

The current coronavirus situation notwithstanding, JD stock is a growth holding investors should keep on their radar.

5 Utility Stocks to Buy for Stability in an Unstable Market

As the global economic and geopolitical environments grow more uncertain, investors will increasingly play defense with these utility stocks.

Coronavirus Fears Have Discounted Freeport-McMoRan Stock

As a copper play, Freeport-McMoRan stock doesn’t look appealing. But with the core asset’s importance, this is a strong discount.

3 Healthcare Stocks to Buy This Week Ahead of Earnings

The markets may be taking a dip, but these three healthcare stocks could be your portfolio's prescription as earnings season is in full swing.

Teva Pharmaceutical Just Got a Little Migraine Relief 

With plans to capture 25% of the market, the nod from the FDA should help reduce the sting of having to abandon its planned use of Ajovy for cluster headaches, a move that was dropped last year after a failed phase 3 trial, which gave Eli Lilly the market to itself.

10 Gold and Silver Stocks to Profit Off 2020’s Fear Trade

Seemingly out of nowhere, fear and uncertainty have clouded the narrative for 2020. But that’s also music to the ears of those investing in gold and silver stocks.